Green Fresh Biotechnology Company Limited will convene its annual general meeting (AGM) on 12 June 2026 at 11:00 a.m. in North Point, Hong Kong. Shareholders will vote on the following key items:

• Financial statements and dividend The board will present the audited consolidated results for the year ended 31 December 2025 and recommend a final dividend of HK1.2 cents per share. The register of members will close from 18 June 2026 to 23 June 2026, with 23 June 2026 set as the record date for dividend entitlement.

• Board composition Resolutions propose re-electing Executive Directors Mr. CHAN Kam Chung and Ms. CHEN Yi, as well as Independent Non-Executive Director Mr. HO Kwai Ching, Mark. Director remuneration will remain subject to board determination.

• Auditor PricewaterhouseCoopers is nominated for re-appointment as external auditor, with fees to be fixed by the board.

• Capital management mandates 1. Share repurchase mandate: authority to buy back up to 10% of issued shares during the mandate period. 2. Issuance mandate: authority to allot and issue new shares up to 20% of issued capital, excluding treasury shares. 3. Extension mandate: authority to extend the issuance limit by the number of shares repurchased, capped at an additional 10% of issued capital.

• Administrative dates The share register will be closed from 9 June 2026 to 12 June 2026 (both days inclusive) to determine eligibility to attend and vote at the AGM, with 12 June 2026 as the record date. Proxy forms must be lodged by 11:00 a.m. on 10 June 2026.

The AGM notice was issued on 24 April 2026 and signed by Chairman and Chief Executive Officer Mr. CHAN Kam Chung.